Trial Profile
A Prospective, Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Atorvastatin Versus Pravastatin on the Progression and Quantification of Coronary Atherosclerotic Lesions as Measured by Intravascular Ultrasound (REVERSAL).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Mar 2009
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Pravastatin (Primary)
- Indications Coronary arteriosclerosis; Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors Pfizer
- 18 Nov 2006 New trial record.